References
- Dani B, Platz R, Tzannis ST. High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration. J Pharm Sci 2007;96:1504–17.
- Marichal-Gallardo PA, Álvarez MM. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation. Biotechnol Prog 2012;28:899–916.
- Kane C, O'Neil K, Conk M, Picha K. Inhalation delivery of protein therapeutics. Inflamm Allergy Drug Targets 2013;12:81–7.
- Schule S, Schulz-Fademrecht T, Garidel P, et al. Stabilization of IgG1 in spray-dried powders for inhalation. Eur J Pharm Biopharm 2008;69:793–807.
- Fahy JV, Cockcroft DW, Boulet LP, et al. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1999;160:1023–7.
- Daugherty AL, Mrsny RJ. Formulation and delivery issues for monoclonal antibody therapeutics. Adv Drug Deliv Rev 2006;58:686–706.
- Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Med Devices 2015;8:131–9.
- Ramezani V, Vatanara A, Najafabadi AR, et al. A comparative study on the physicochemical and biological stability of IgG 1 and monoclonal antibodies during spray drying process. DARU J Pharm Sci 2014;22:1.
- Chow A, Tong H, Chattopadhyay P, Shekunov B. Particle engineering for pulmonary drug delivery. Pharm Res 2007;24:411–37.
- Wang W, Singh S, Zeng DL, et al. Antibody structure, instability, and formulation. J Pharm Sci 2007;96:1–26.
- Chang LL, Shepherd D, Sun J, et al. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci 2005;94:1427–44.
- Andya JD, Maa YF, Costantino HR, et al. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm Res 1999;16:350–8.
- Costantino HR, Andya JD, Nguyen PA, et al. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J Pharm Sci 1998;87:1406–11.
- Ramezani V, Vatanara A, Najafabadi AR, et al. Screening and evaluation of variables in the formation of antibody particles by spray drying. Powder Technol 2013;233:341–6.
- Chen B, Bautista R, Yu K, et al. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms. Pharm Res 2003;20:1952–60.
- Faghihi H, Vatanara A, Najafabadi AR, et al. The use of amino acids to prepare physically and conformationally stable spray-dried IgG with enhanced aerosol performance. Int J Pharm 2014;466:163–71.
- Fernández M, Villalonga ML, Fragoso A, et al. Effect of β-cyclodextrin-polysucrose polymer on the stability properties of soluble trypsin. Enzyme Microb Technol 2004;34:78–82.
- Castellanos IJ, Flores G, Griebenow K. Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. J Pharm Sci 2006;95:849–58.
- Serno T, Geidobler R, Winter G. Protein stabilization by cyclodextrins in the liquid and dried state. Adv Drug Deliv Rev 2011;63:1086–106.
- Iwai J, Ogawa N, Nagase H, et al. Effects of various cyclodextrins on the stability of freeze‐dried lactate dehydrogenase. J Pharm Sci 2007;96:3140–3.
- Santagapita PR, Brizuela LG, Mazzobre MF, et al. β-Cyclodextrin modifications as related to enzyme stability in dehydrated systems: Supramolecular transitions and molecular interactions. Carbohydr Polym 2011;83:203–9.
- Mohajel N, Najafabadi AR, Azadmanesh K, et al. Optimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex. Int J Pharm 2012;423:577–85.
- Nahata T, Saini TR. D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole. Drug Dev Ind Pharm 2008;34:668–75.
- Kamairudin N, Gani SS, Masoumi HR, Hashim P. Optimization of natural lipstick formulation based on pitaya (Hylocereus polyrhizus) seed oil using D-optimal mixture experimental design. Molecules 2014;19:16672–83.
- Mahler HC, Friess W, Grauschopf U, Kiese S. Protein aggregation: Pathways, induction factors and analysis. J Pharm Sci 2009;98:2909–34.
- Kong J, Yu S. Fourier transform infrared spectroscopic analysis of protein secondary structures. Acta Biochim Biophys Sin (Shanghai) 2007;39:549–59.
- Food, Administration D. Guidance for industry Q1A (R2) stability testing of new drug substances and products. Rockville, MD: Food and Drug Administration; 2003.
- Maa YF, Nguyen PA, Sit K, Hsu CC. Spray-drying performance of a bench-top spray dryer for protein aerosol powder preparation. Biotechnol Bioeng 1998;60:301–9.
- Elversson J, Millqvist-Fureby A, et al. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J Pharm Sci 2003;92:900–10.
- Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res 2008;25:999–1022.
- Chatjigakis AK, Donze C, Coleman AW, Cardot P. Solubility behavior of.beta.-cyclodextrin in water/cosolvent mixtures. Anal Chem 199264:1632–4.
- Häusler O, Müller‐Goymann CC. Properties and structure of aqueous solutions of hydroxypropyl‐beta‐cyclodextrin. Starch‐Stärke 1993;45:183–7.
- Feng AL, Boraey MA, Gwin MA, et al. Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery. Int J Pharm 2011;409:156–63.
- Adler M, Unger M, Lee G. Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant. Pharm Res 2000;17:863–70.
- Adler M, Lee G. Stability and surface activity of lactate dehydrogenase in spray-dried trehalose. J Pharm Sci 1999;88:199–208.
- Ishiguro T, Morishita E, Iohara D, et al. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative. Int J Pharm 2011;419:161–9.
- Iskandar F, Gradon L, Okuyama K. Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. J Colloid Interface Sci 2003;265:296–303.
- Kaushik JK, Bhat R. Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose. J Biol Chem 2003;278:26458–65.
- Maa YF, Nguyen PA, Sweeney T, et al. Protein inhalation powders: spray drying vs spray freeze drying. Pharm Res 1999;16:249–54.
- Hooton JC, Jones MD, Price R. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J Pharm Sci 2006;95:1288–97.
- Li HY, Seville PC, Williamson IJ, Birchall JC. The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy. J Gene Med 2005;7:1035–43.
- Srichana T, Suedee R, Reanmongkol W. Cyclodextrin as a potential drug carrier in salbutamol dry powder aerosols: the in-vitro deposition and toxicity studies of the complexes. Respir Med 2001;95:513–19.
- Vozone CM, Marques HMC. Complexation of budesonide in cyclodextrins and particle aerodynamic characterization of the complex solid form for dry powder inhalation. J Incl Phenom Macrocycl Chem 2002;44:111–16.
- Carpenter JF, Crowe JH. An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. Biochemistry 1989;28:3916–22.
- Chang LL, Shepherd D, Sun J, et al. Effect of sorbitol and residual moisture on the stability of lyophilized antibodies: Implications for the mechanism of protein stabilization in the solid state. J Pharm Sci 2005;94:1445–55.
- Branchu S, Forbes RT, York P, et al. Hydroxypropyl‐β‐cyclodextrin inhibits spray‐drying‐induced inactivation of β‐galactosidase. J Pharm Sci 1999;88:905–11.
- Tavornvipas S, Hirayama F, Takeda S, et al. Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor. J Pharm Sci 2006;95:2722–9.
- Loftsson T, Jarho P, Masson M, Järvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2005;2:335–51.
- Otzen DE, Knudsen BR, Aachmann F, et al. Structural basis for cyclodextrins' suppression of human growth hormone aggregation. Protein Sci 2002;11:1779–87.
- Chang LL, Shepherd D, Sun J, et al. Mechanism of protein stabilization by sugars during freeze‐drying and storage: Native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci 2005;94:1427–44.
- Allison SD, Chang B, Randolph TW, Carpenter JF. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch Biochem Biophys 1999;365:289–98.
- Schüle S, Frieß W, Bechtold-Peters K, Garidel P. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations. Eur J Pharm Biopharm 2007;65:1–9.
- Maury M, Murphy K, Kumar S, et al. Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G. Eur J Pharm Biopharm 2005;59:251–61.
- Tian F, Middaugh CR, Offerdahl T, et al. Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations. Int J Pharm 2007;335:20–31.